National Science and Technology Institute for Translational Medicine (INCT-TM): Advancing the field of translational medicine and mental health

Revista Brasileira de Psiquiatria

Volumn 32, Issue 1, 2010, Pages 83-90

  Hallak, Jaime E C ^a,b   Crippa, José Alexandre S ^a,b   Quevedo, João ^a,c   Roesler, Rafael ^a,d,e   Schröder, Nadja ^a,f   Nardi, Antonio Egidio ^a,g   Kapczinski, Flávio ^a,e  

^a National Institute for Science and Technology INCT Translational Medicine   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^f PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Biomarkers pharmacological; Biomedical research; Innovation; Mental health; Technological development

Indexed keywords

ACETYLCYSTEINE; AMPHETAMINE; ANTINEOPLASTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABIDIOL; GASTRIN RELEASING PEPTIDE RECEPTOR; HISTONE DEACETYLASE INHIBITOR; IRON CHELATING AGENT; LITHIUM; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NOOTROPIC AGENT; VALPROIC ACID;

AGORAPHOBIA; ARTICLE; BIPOLAR DISORDER; BIPOLAR MANIA; BRAIN DISEASE; BRAIN FUNCTION; CELL CULTURE; CELL PROLIFERATION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DNA DAMAGE; HUMAN; LOCOMOTION; MEMORY; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH RESEARCH; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PANIC; PUBLIC SPEAKING; RESOURCE MANAGEMENT; SCHIZOPHRENIA; SOCIAL PHOBIA; TECHNOLOGY; VIRTUAL REALITY;

EID: 77950537848     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462010000100016     Document Type: Article

References (40)

1. Marincola FM. Translational medicine: a two way road. J Transl Med. 2003;1(1):1.
2. Littman BH, Di Mario L, Plebani M, Marincola FM. What's next in translational medicine? Clin Sci (Lond). 2007;112(4):217-227
3. Vieta E. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Hum Psychopharmacol. 2005;20(5):225-236
4. Zarate CA, Jr Singh J, Manji HK. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry. 2006;59(11):1006-1020
5. Manji HK, Chen G. PKC, MAP kinases and bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry. 2002;7 Suppl 1:S46-56.
6. Einat H, Yuan P, Gould TD, Li J, Du J, Manji HK, Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003;23(19):7311-7316
7. Lamberty Y, Margineanu DG, Klitgaard H. Effect of the new antiepileptic drug levetiracetam in an animal model of mania. Epilepsy Behav. 2001;2(5):454-459
8. Machado-Vieira R, Schmidt AP, Avila TT, Kapczinski F, Soares JC, Souza DO, Portela LV. Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain. Life Sci. 2004;76(7): 805-811
9. Ellenbroek BA, Cools AR. Animal models with construct validity for schizophrenia. Behav Pharmacol. 1990;1(6):469-490
10. Belmaker RH. Bipolar disorder. N Engl J Med. 2004;351(5):476-486
11. Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE Jr, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64(6):680-690
12. Frey BN, Andreazza AC, Ceresér KM, Martins MR, Valvassori SS, Réus GZ, Quevedo J, Kapczinski F. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci. 2006a;79(3):281-286
13. Frey BN, Valvassori SS, Réus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res. 2006b;31(5):699-703.
14. Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F. Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord. 2006c;8(3):275-280
15. Frey BN, Valvassori SS, Gomes KM, Martins MR, Dal-Pizzol F, Kapczinski F, Quevedo J. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 2006d;1097(1):224-229
16. Frey BN, Valvassori SS, Réus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci. 2006e;31(5):326-332
17. Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Réus GZ, Hatch JP, Quevedo J, Kapczinski F. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol. 2006f;17(4):311-318
18. Fernandes BS, Gama CS, Kauer-Sant'Anna M, Lobato MI, Belmonte-de-Abreu P, Kapczinski F. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res. 2009;43(15):1200-1204
19. Tramontina JF, Andreazza AC, Kauer-Sant'anna M, Stertz L, Goi J, Chiarani F, Kapczinski F. Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett. 2009;452(2):111-113
20. Yumru M, Savas HA, Kalenderoglu A, Bulut M, Celik H, Erel O. Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharm Biol Psychiatry. 2009;33(6):1070-1074
21. Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant'Anna M, Cunha AB, Post RM. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr. 2008;30(3):243-245
22. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Gonçalves CA, Kapczinski F. DNA damage in bipolar disorder. Psychiatry Res. 2007;153(1):27-32.
23. de Lima MN, Laranja DC, Caldana F, Grazziotin MM, Garcia VA, Dal-Pizzol F, Bromberg E, Schröder N. Selegiline protects against recognition memory impairments induced by neonatal iron treatment. Exp Neurol. 2005;196(1):177-183
24. de Lima MN, Polydoro M, Laranja DC, Bonatto F, Bromberg E, Moreira JC, Dal-Pizzol F, Schröder N. Recognition memory impairment and brain oxidative stress by postnatal iron administration. Eur J Neurosci. 2005a;21(9):2521-2528
25. de Lima MN, Presti-Torres J, Garcia VA, Guimarães MR, Scalco FS, Roesler R, Schröder N. Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats. Neuropharmacology. 2008a;55(5):788-792
26. Schröder N, Fredriksson A, Vianna MR, Roesler R, Izquierdo I, Archer T. Memory deficits in adult rats following postnatal iron administration. Behav Brain Res. 2001;124(1):77-85.
27. de Lima MN, Laranja DC, Caldana F, Bromberg E, Roesler R, Schröder N. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp Gerontol. 2005b; 40(6):506-511
28. de Lima MN, Dias CP, Torres JP, Dornelles A, Garcia VA, Scalco FS, Guimarães MR, Petry RC, Bromberg E, Constantino L, Budni P, Dal-Pizzol F, Schröder N. Reversion of age-related recognition memory impairment by iron chelation in rats. Neurobiol Aging. 2008b;29(7):1052-1059
29. Dias CP, De Lima MN, Torres J, Dornelles AS, Garcia VA, Scalco F, Guimarães M, Constantino L, Budni P, Dal-Pizzol F, Schöder N. Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neurosci. 2007;146(4):1719-1725
30. Flores DG, de Farias CB, Leites J, de Oliveira MS, Lima RC, Tamajusuku AS, Di Leone LP, Meurer L, Brunetto AL, Schwartsmann G, Lenz G, Roesler R. Gastrin-releasing peptide receptors regulate proliferation of C6 glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism. Curr Neurovasc Res. 2008;5(2):99-105.
31. Farias CB, Lima RC, Lima LO, Flores DG, Meurer L, Brunetto AL, Schwartsmann G, Roesler R. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling. Oncology. 2008;75(1-2):27-31.
32. Roesler R, Quevedo J. Retrieval mediated by hippocampal extracellular signal-regulated kinase/mitogen-activated protein kinase is required for memory strengthening. Neuroscience. 2009;160(4):711-715
33. Roesler R, Luft T, Oliveira SH, Farias CB, Almeida VR, Quevedo J, Dal Pizzol F, Schröder N, Izquierdo I, Schwartsmann G. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus. Neuropharmacology. 2006;51(2):350-357
34. Roesler R, Valvassori SS, Castro AA, Luft T, Schwartsmann G, Quevedo J. Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus. Peptides. 2009;30(6):1192-1196
35. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. San Diego: Academic Press; 2007.
36. McNair DM, Frankenthaler LM, Czerlinsky T, White TW, Sasson S, Fisher S. Simulated public speaking as a model of human anxiety. Psychopharmacology. 1982;77(1):7-10.
37. Wilson PN, Foreman N, Tlauka M. Transfer of spatial information from a virtual to a real environment. Hum Factors. 1997;39(4):526-531
38. Choi Y, Vincelli F, Riva G, Wiederhold BK, Lee J, Park K. Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia. Cyberpsychol Behav. 2005;8(4):387-393
39. Tramontina JF, Yates D, Magalhães PV, Trentini C, Sant'anna MK, Fries GR, Bock H, Saraiva-Pereira ML, Kapczinski F. Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Rev Bras Psiquiatr. 2009;31(2):136-140
40. Kapczinski F, Hallak JE, Nardi AE, Roesler R, Quevedo J, Schröder N, Crippa JA. Brazil launches an innovative program to develop the National Institutes for Science and Technology (INCTs): the INCT for Translational Medicine. Rev Bras Psiquiatr. 2009;31(3):197-199